Silencing of Carboxypeptidase E Expression Inhibits Proliferation and Invasion of Panc-1 Pancreatic Cancer Cells

Overview

Journal F1000Res

Specialties Biomedical Engineering
Science

Date 2022 May 10

PMID 35528956

Authors

Hong Lou

Y Peng Loh

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer is one of the leading cause of cancer-related death globally. The molecular basis of this disease is complex and not fully understood. Previous studies have indicated that carboxypeptidase E (CPE) plays a role in promoting tumorigenesis in many cancer types. Here we have investigated the effect of carboxypeptidase E (CPE), including its isoform, in regulating the proliferation, migration and invasion of Panc-1 cells, a pancreatic cell line. Panc-1 cells were transfected with CPE siRNA which targets both CPE-wild type and its isoform, or scrambled siRNA, for 24 h and then assayed for proliferation by the MTT and colony formation assays, and migration and invasion by wound healing and matrigel assays, respectively. CPE siRNA treatment of Panc-1 cells down-regulated the expression of CPE mRNA by 94.8%. Silencing of CPE mRNA expression resulted in a significant decrease in proliferation as revealed by the MTT assay and a 62.8% decrease in colony formation. Western blot analysis of expression of Cyclin D1 in Panc-1 cells treated with CPE siRNA showed a decrease of 32.5% compared to scr siRNA treated cells, indicating that CPE regulates proliferation through modulating this cell cycle protein. Additionally, suppression of CPE expression in Panc-1 cells significantly decreased migration and invasion. Our findings indicate that CPE may play an important role in regulating cell proliferation, migration and invasion to promote pancreatic cancer tumorigenesis.

Citing Articles

CPE correlates with poor prognosis in gastric cancer by promoting tumourigenesis.

Lin J, Huang C, Diao W, Liu H, Lu H, Huang S Heliyon. 2024; 10(9):e29901.

PMID: 38694095 PMC: 11058891. DOI: 10.1016/j.heliyon.2024.e29901.

New gene signature from the dominant infiltration immune cell type in osteosarcoma predicts overall survival.

Gong L, Sun X, Jia M Sci Rep. 2023; 13(1):18271.

PMID: 37880378 PMC: 10600156. DOI: 10.1038/s41598-023-45566-6.

Carboxypeptidase E and its splice variants: Key regulators of growth and metastasis in multiple cancer types.

Hareendran S, Yang X, Sharma V, Loh Y Cancer Lett. 2022; 548:215882.

PMID: 35988818 PMC: 9532369. DOI: 10.1016/j.canlet.2022.215882.

Silencing of Carboxypeptidase E expression inhibits proliferation and invasion of Panc-1 pancreatic cancer cells.

Lou H, Loh Y F1000Res. 2022; 10:489.

PMID: 35528956 PMC: 9069412. DOI: 10.12688/f1000research.53737.2.

References

Sun J, Meng D, Li L, Tian X, Jia Y, Wang H . N-terminal truncated carboxypeptidase E expression is associated with poor prognosis of lung adenocarcinoma. Oncol Lett. 2017; 12(6):4659-4664. PMC: 5228318. DOI: 10.3892/ol.2016.5283. View

Rawla P, Sunkara T, Gaduputi V . Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019; 10(1):10-27. PMC: 6396775. DOI: 10.14740/wjon1166. View

Horing E, Harter P, Seznec J, Schittenhelm J, Buhring H, Bhattacharyya S . The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress. Acta Neuropathol. 2012; 124(1):83-97. DOI: 10.1007/s00401-011-0940-x. View

Fan S, Li X, Li L, Wang L, Du Z, Yang Y . Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cells. Onco Targets Ther. 2016; 9:2795-803. PMC: 4869623. DOI: 10.2147/OTT.S98991. View

Liu A, Shao C, Jin G, Liu R, Hao J, Shao Z . Downregulation of CPE regulates cell proliferation and chemosensitivity in pancreatic cancer. Tumour Biol. 2014; 35(12):12459-65. DOI: 10.1007/s13277-014-2564-y. View

Kamerkar S, LeBleu V, Sugimoto H, Yang S, Ruivo C, Melo S . Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017; 546(7659):498-503. PMC: 5538883. DOI: 10.1038/nature22341. View

Shen H, Tan J, Shang J, Hou M, Liu J, He L . CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer. Arch Gynecol Obstet. 2015; 294(2):333-42. DOI: 10.1007/s00404-015-3985-6. View

Liang X, Li L, Wu G, Xie Y, Zhang G, Chen W . Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer. BMC Cancer. 2013; 13:412. PMC: 3844403. DOI: 10.1186/1471-2407-13-412. View

Hareendran S, Yang X, Lou H, Xiao L, Loh Y . Carboxypeptidase E-∆N Promotes Proliferation and Invasion of Pancreatic Cancer Cells via Upregulation of CXCR2 Gene Expression. Int J Mol Sci. 2019; 20(22). PMC: 6888591. DOI: 10.3390/ijms20225725. View

10.

Hook V, Eiden L, Brownstein M . A carboxypeptidase processing enzyme for enkephalin precursors. Nature. 1982; 295(5847):341-2. DOI: 10.1038/295341a0. View

11.

Yang X, Lou H, Chen Y, Huang S, Loh Y . A novel 40kDa N-terminal truncated carboxypeptidase E splice variant: cloning, cDNA sequence analysis and role in regulation of metastatic genes in human cancers. Genes Cancer. 2019; 10(5-6):160-170. PMC: 6872665. DOI: 10.18632/genesandcancer.193. View

12.

Xiao L, Yang X, Sharma V, Loh Y . Cloning, gene regulation, and neuronal proliferation functions of novel N-terminal-truncated carboxypeptidase E/neurotrophic factor-αl variants in embryonic mouse brain. FASEB J. 2018; 33(1):808-820. PMC: 6355066. DOI: 10.1096/fj.201800359R. View

13.

Cawley N, Wetsel W, Murthy S, Park J, Pacak K, Loh Y . New roles of carboxypeptidase E in endocrine and neural function and cancer. Endocr Rev. 2012; 33(2):216-53. PMC: 3365851. DOI: 10.1210/er.2011-1039. View

14.

Selvaraj P, Xiao L, Lee C, Murthy S, Cawley N, Lane M . Neurotrophic Factor-α1: A Key Wnt-β-Catenin Dependent Anti-Proliferation Factor and ERK-Sox9 Activated Inducer of Embryonic Neural Stem Cell Differentiation to Astrocytes in Neurodevelopment. Stem Cells. 2016; 35(3):557-571. PMC: 6131007. DOI: 10.1002/stem.2511. View

15.

Murthy S, Dupart E, Al-Sweel N, Chen A, Cawley N, Loh Y . Carboxypeptidase E promotes cancer cell survival, but inhibits migration and invasion. Cancer Lett. 2013; 341(2):204-13. PMC: 3825807. DOI: 10.1016/j.canlet.2013.08.011. View

16.

Bai Z, Feng M, Du Y, Cong L, Cheng Y . Carboxypeptidase E down-regulation regulates transcriptional and epigenetic profiles in pancreatic cancer cell line: A network analysis. Cancer Biomark. 2020; 29(1):79-88. DOI: 10.3233/CBM-191163. View

17.

Huang S, Wu H, Chen Y, Murthy S, Chiu Y, Chang Y . Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma. Tumour Biol. 2016; 37(7):9745-53. DOI: 10.1007/s13277-016-4814-7. View

18.

Chougule A, Kolli V, Baroi S, Ebraheim N, Czernik P, Loh Y . Nonenzymatic and Trophic Activities of Carboxypeptidase E Regulate Bone Mass and Bioenergetics of Skeletal Stem Cells in Mice. JBMR Plus. 2020; 4(9):e10392. PMC: 7507073. DOI: 10.1002/jbm4.10392. View

19.

Lou H, Loh Y . Silencing of Carboxypeptidase E expression inhibits proliferation and invasion of Panc-1 pancreatic cancer cells. F1000Res. 2022; 10:489. PMC: 9069412. DOI: 10.12688/f1000research.53737.2. View

20.

Fricker L . Carboxypeptidase E. Annu Rev Physiol. 1988; 50:309-21. DOI: 10.1146/annurev.ph.50.030188.001521. View